Australia's largest stock trading and investment forum Australia's #1 stock forum

CPH

Click for more information

0.00%

0.9¢ creso pharma limited

None of your arguments are factual and your uneducated...

First 66 Last

Share
Profile

Follow
goldentrade

214 Posts.

8

01/04/21

10:11

Post #: 52196678
Share

Originally posted by FraserJC: ↑

I have helped introduce a new modality to help treat a range of musculoskeletal issues. I know first hand how incredibly inert and inherently risk-averse the the medical profession is to new ideas and approaches. They are even more resistant to adopt treatments based on compounds that they were told were "illegal drugs" in med school, such as magic mushrooms.

There is no massive market right now for the widespread use of them to treat mental health ailments. It is the new kid on the block amongst a wide range of clinically-proven treatment options. It will take years to complete enough clinical trials. Even then, you still have to change the conventional wisdom of the profession itself. That takes time. Same with weed, and that is 10 or 20 years down the track from mushies.

Like I said, mushies are a commercial dead end for at least the next 5 to 10 years, so I'm not sure why you think this is such a windfall. Creso will spend tens of millions trying to establish this product, which must then be recovered from their absolutely miniscule GP. The maths is not good.

Expand

None of your arguments are factual and your uneducated opinion.

Do some research...,

CPH Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

OPL

Opyl forms JV with UK and US consortium to bring products to the world

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

There are more pages in this discussion • 309 more messages in this thread...

First 66 Last

Add CPH (ASX) to my watchlist